搜索结果：Neurotherapeutics

Magnetic nanoparticles (MNPs) are the foundation of several new strategies for neural repair and neurological therapies. The fact that a remote force can act on MNPs at the cytoplasmic space constitutes the essence of many new neurotherapeutic concepts. MNPs with a predesigned physicochemical characteristic can interact with external magnetic fields to apply mechanical forces in definite areas of the cell to modulate cellular behaviour. Magnetic actuation to direct the outgrowth on neurons after nerve injury has already demonstrated the therapeutic potential for neural repair. When these magnetic cores are functionalized with molecules such as nerve growth factors or neuroprotective molecules, multifunctional devices can be developed. This chapter will review some of these new nanotechnology-based solutions for neurological diseases, specifically those based on the use of engineered MNPs used for neuroprotection and neuroregeneration. These include the use of MNPs as magnetic actuators to guide neural cells, modulate intracellular transport and stimulate axonal growth after nerve injury.

The strict selectivity of the blood-brain barrier (BBB) represents one of the most formidable challenges to successful central nervous system (CNS) drug delivery. Computational methods to generate BBB permeable drugs in silico may be valuable tools in the CNS drug design pipeline. However, in real-world applications, BBB penetration alone is insufficient; rather, after transiting the BBB, molecules must bind to a specific target or receptor in the brain and must also be safe and non-toxic. To discover small molecules that concurrently satisfy these constraints, we use multi-objective generative AI to synthesize drug-like BBB-permeable small molecules. Specifically, we computationally synthesize molecules with predicted binding affinity against dopamine receptor D2, the primary target for many clinically effective antipsychotic drugs. After training several graph neural network-based property predictors, we adapt SyntheMol (Swanson et al., 2024), a recently developed Monte Carlo Tree Search-based algorithm for antibiotic design, to perform a multi-objective guided traversal over an easily synthesizable molecular space. We design a library of 26,581 novel and diverse small molecules